Financial Consulate, Inc Illumina, Inc. Transaction History

Financial Consulate, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$193.75 - $232.55 $6,006 - $7,209	31 Added 1.87%	1,692 $393,000
Q4 2022 Jan 11, 2023	BUY	$187.24 - $242.74 $8,238 - $10,680	44 Added 2.72%	1,661 $0
Q3 2022 Oct 20, 2022	BUY	$177.23 - $227.44 $9,570 - $12,281	54 Added 3.45%	1,617 $309,000
Q2 2022 Jul 19, 2022	BUY	$181.58 - $368.0 $47,755 - $96,784	263 Added 20.23%	1,563 $288,000
Q1 2022 Apr 28, 2022	BUY	$303.87 - $423.8 $12,154 - $16,952	40 Added 3.17%	1,300 $454,000
Q4 2021 Feb 07, 2022	BUY	$347.28 - $421.83 $112,171 - $136,251	323 Added 34.47%	1,260 $479,000
Q3 2021 Oct 19, 2021	BUY	$405.61 - $524.84 $42,589 - $55,108	105 Added 12.62%	937 $380,000
Q2 2021 Jul 22, 2021	BUY	$372.84 - $481.5 $39,521 - $51,039	106 Added 14.6%	832 $394,000
Q1 2021 Apr 19, 2021	BUY	$361.28 - $504.76 $49,134 - $68,647	136 Added 23.05%	726 $279,000
Q4 2020 Jan 29, 2021	BUY	$292.7 - $370.96 $172,693 - $218,866	590 New	590 $218,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.